| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/15/2011 | US7906624 Binding peptidomimetics and uses of the same |
| 03/15/2011 | US7906623 Defatting collagen |
| 03/15/2011 | US7906620 Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines |
| 03/15/2011 | US7906619 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
| 03/15/2011 | US7906618 Peptide capable of binding to insulin-binding protein and adsorbent |
| 03/15/2011 | US7906616 Truncated DANCE, DANCE complex and method of using these |
| 03/15/2011 | US7906550 Viricide against hepatitis virus; pyrrole derivatives as, for example, 3-acetyl-4,5-dimethyl-2-pyrrole carboxylic acid |
| 03/15/2011 | US7906490 Using vector transformation to generate transgenic cells expressing interfering RNA sequences; treatment and prevention of metabolic disorders |
| 03/15/2011 | US7906486 Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa |
| 03/15/2011 | US7906485 Erythropoietin receptor peptide formulations and uses |
| 03/15/2011 | US7906484 Complex for transferring an anionic substance into a cell |
| 03/15/2011 | US7906483 Method for treating transplant rejection |
| 03/15/2011 | US7906482 Peptide YY (PYY) coupled to a group capable of reacting on a blood component so as to form a stable covalent bond, preventing said PYY peptide from crossing the blood brain barrier; improved bioavailability; reduce tumor necrosis factor (TNF)-induced acute pancreatitis |
| 03/15/2011 | US7906481 Using tumor necrosis factor inhibitor as therapeutic agent in treatment of spinal cord injury and nervous system disorders |
| 03/15/2011 | US7906480 Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy |
| 03/15/2011 | US7906479 Lyophilizates of active, excipients, carriers, bulking agents; medicaments for benign or malignant neoplastic diseases, hormone therapy, treatment of fertility disorders, contraception, HIV infections, neurological or neurodegenerative disorders; high bioavailability |
| 03/15/2011 | US7906478 Personal-care articles having self-assembling peptides |
| 03/15/2011 | US7906477 Proteases of human kallikrein 2 (hK2); tissue imaging |
| 03/15/2011 | US7906308 Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex |
| 03/15/2011 | US7906277 Compound and methods for diagnosis of tuberculosis |
| 03/15/2011 | US7906150 Preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium |
| 03/15/2011 | US7906146 Lyophilized formulations of exendins and exendin agonist analogs |
| 03/15/2011 | US7906140 Compositions for mucosal delivery of agents |
| 03/15/2011 | US7906137 Delivery agents for enhancing mucosal absorption of therapeutic agents |
| 03/15/2011 | US7906121 Methods and compositions for generating bioactive assemblies of increased complexity and uses |
| 03/15/2011 | US7906118 Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology |
| 03/15/2011 | US7906114 Compositions for promoting wound healing and treating psoriasis |
| 03/15/2011 | US7906112 Canine probiotic Lactobacilli |
| 03/15/2011 | US7906109 Pharmaceutical composition comprising an active principal and sulphobetaine |
| 03/15/2011 | CA2677910C The use of inhibitors of the renin-angiotensin system for the treatment of cardiovascular diseases |
| 03/15/2011 | CA2562982C Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 03/15/2011 | CA2538085C Synthetic antimicrobial polypeptides |
| 03/15/2011 | CA2529062C Antimicrobial polypeptides |
| 03/15/2011 | CA2494698C Anti-idiotypic antibodies against factor viii inhibitor and uses thereof |
| 03/15/2011 | CA2480708C Method and dietary composition for improving fat digestibility |
| 03/15/2011 | CA2470583C Prevention and treatment of oxidative stress disorders by glutathione and phase ii detoxification enzymes |
| 03/15/2011 | CA2470423C Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 03/15/2011 | CA2451718C Sustained-release composition comprising lactic acid-glycolic acid copolymer and process for producing the same |
| 03/15/2011 | CA2433806C Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 03/15/2011 | CA2404196C Medical emulsion for lubrication and delivery of drugs |
| 03/15/2011 | CA2396030C Camptothecin .beta.-alanine esters with topoisomerase i inhibition |
| 03/15/2011 | CA2389302C Delivery of proteins across polar epithelial cell layers |
| 03/15/2011 | CA2374398C Immunoconjugates having high binding affinity |
| 03/15/2011 | CA2338982C Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 03/15/2011 | CA2271762C Use of sphingomyelinase to increase the levels of skin and mucosal ceramides, and dermatological and cosmetic compositions suitable for topical application containing same |
| 03/15/2011 | CA2202875C Process for purifying factor viii |
| 03/15/2011 | CA2188422C Bifunctional protein, preparation and use |
| 03/10/2011 | WO2011029102A2 Cd117+cells and uses thereof |
| 03/10/2011 | WO2011029082A1 Durable treatment with 4-aminopyridine in patients with demyelination |
| 03/10/2011 | WO2011029028A2 Targeted delivery using tissue-specific peptidomimetic ligands |
| 03/10/2011 | WO2011029008A2 Synbodies to akt1 |
| 03/10/2011 | WO2011028941A2 Disabling autophagy as a treatment for lysosomal storage diseases |
| 03/10/2011 | WO2011028915A2 Platelet aggregation inhibitors |
| 03/10/2011 | WO2011028883A2 Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| 03/10/2011 | WO2011028813A2 Insulin analogues of enhanced receptor-binding specificity |
| 03/10/2011 | WO2011028673A2 A composition for delaying cellular senescence |
| 03/10/2011 | WO2011028618A1 Composition and method for reducing blood glucose levels |
| 03/10/2011 | WO2011028485A2 Tumoricidal, bactericidal, or viricidal macrophage activation |
| 03/10/2011 | WO2011028416A2 Oral medication for the treatment of hemorrhoids and method of use |
| 03/10/2011 | WO2011028410A2 Topical medication for the treatment of hemorrhoids and method of use |
| 03/10/2011 | WO2011028406A2 Soaking agent for the treatment of hemorrhoids and method of use |
| 03/10/2011 | WO2011028344A2 Interleukin-1 receptor antagonist compositions and methods of making and using same |
| 03/10/2011 | WO2011028228A1 Coagulation factor vii compositions and methods of making and using same |
| 03/10/2011 | WO2011028195A2 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 03/10/2011 | WO2011028173A1 Method of treatment of a patient suffering from an infection or injuries caused or complicated by infection |
| 03/10/2011 | WO2011028064A2 Novel bacteriophage and antibacterial composition comprising the same |
| 03/10/2011 | WO2011028061A2 Novel bacteriophage and antibacterial composition comprising the same |
| 03/10/2011 | WO2011028059A2 Novel bacteriophage and antibacterial composition comprising the same |
| 03/10/2011 | WO2011028057A2 Novel bacteriophage and antibacterial composition comprising the same |
| 03/10/2011 | WO2011027980A2 Tumor cell-killing peptides |
| 03/10/2011 | WO2011027941A1 Wnt10-derived peptide and use thereof |
| 03/10/2011 | WO2011027916A1 Therapeutic agent for allergic diseases |
| 03/10/2011 | WO2011027893A1 Method for prediction of therapeutic effect on chronic hepatitis c |
| 03/10/2011 | WO2011027850A1 Bone regeneration agent including gelatin |
| 03/10/2011 | WO2011027839A1 Cholesterol-efflux peptide |
| 03/10/2011 | WO2011027807A1 Immunity inducer |
| 03/10/2011 | WO2011027330A1 Inhibition of histone acetyltransferases by ctk7a and methods thereof |
| 03/10/2011 | WO2011027290A1 Antibiotic compounds |
| 03/10/2011 | WO2011027175A1 Antithrombotic compounds |
| 03/10/2011 | WO2011027152A1 Stable formulation of factor viii |
| 03/10/2011 | WO2011027048A1 Transglutaminase-activating peptide, and cosmetic or pharmaceutical composition containing same |
| 03/10/2011 | WO2011026815A1 Compositions and methods for treating growth hormone deficiency |
| 03/10/2011 | WO2011026615A1 Modified agrin-fragment capable of restoring muscle strength for use as a medicament |
| 03/10/2011 | WO2011026447A1 New antibiotic containing simulacrum antibody, preparation method and application thereof |
| 03/10/2011 | WO2011026362A1 Use of cobrotoxin for manufacturing a medicament for the treatment of arthritis |
| 03/10/2011 | WO2011026351A1 A cyanovirin n mutant, modified derivative and uses thereof |
| 03/10/2011 | WO2011026206A1 Isolated nucleic acid sequence, expression vector, synergistic immunogenic composition comprising an expression vector that codes for the e7 protein of human papilloma virus (hpv) fused with the gd-protein of human herpes virus type-1 (hsv-1), and an expression vector that codes for a cytokyne, and uses thereof |
| 03/10/2011 | WO2011018672A8 Methods and substances for stimulating muscle regeneration |
| 03/10/2011 | WO2010144874A3 Clusterin pharmaceuticals and treatment methods using the same |
| 03/10/2011 | WO2010139736A3 Recombinant production of peptides |
| 03/10/2011 | WO2010135527A9 Elastin for soft tissue augmentation |
| 03/10/2011 | WO2010130418A3 Treatment of eye diseases using encapsulated cells encoding and secreting a neuroprotective factor and/or an anti-angiogenic factor |
| 03/10/2011 | WO2010129947A3 Alpha thymosin peptides as vaccine enhancers |
| 03/10/2011 | WO2010129655A3 Natriuretic polypeptides having mutations within their disulfide rings |
| 03/10/2011 | WO2010129347A3 Compositions and methods for the treatment of disorders involving epithelial cell apoptosis |
| 03/10/2011 | WO2010128521A3 Short-chain peptides as parathyroid hormone (pth) receptor agonist |
| 03/10/2011 | WO2010124296A3 Compositions containing hc•ha complex and methods of use thereof |
| 03/10/2011 | WO2010120121A3 Target-specific non-antibody protein and method for preparing the same |
| 03/10/2011 | WO2010115053A9 Methods of using canonical wnts as enhancers for bone formation by human bone-marrow derived mesenchymal stem cells |
| 03/10/2011 | WO2010114628A3 Formulation for inducing broadly reactive neutralizing anti-hiv antibodies |